Tango Therapeutics, Inc. TNGX 深 沪
等待开盘 06-26 09:30:00 美东时间
30.15
+1.035
+3.55%
华盛通- 最 高31.14
- 今 开29.35
- 成交量 404.48万股
- 最 低 27.65
- 昨 收 29.115
- 总市值 265.01万
- 52周最高 34.39
- 市盈率 静 --
- 换手率 4601.70%
- 52周最低 5.3401
- 委 比 -76.84%
- 总股本 8.79万
- 历史最高 34.39
- 量 比 0.70
- 振 幅 11.99%
- 历史最低 1.0396
- 每 手 1
- 风险率 6.94%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Tango Therapeutics Launches $500M Common Stock Offering
Tango Therapeutics, Inc. ("Tango") (NASDAQ:TNGX), a clinical-stage biotechnology company committed to discovering and delivering the next generation of precision cancer medicines, announced today the launch of an
06-09 04:01
Why Is Tango Therapeutics Stock Soaring Monday?
Tango Therapeutics reports 90% 6-month PFS in pancreatic cancer trial. Read about the vopimetostat combo driving TNGX stock up.
06-08 19:46
Crude Oil Surges 3%; RBC Bearings Earnings Top Views
US stocks down, S&P 500 falls 1%; Dow down 1.08%, NASDAQ down 1.42%. Energy shares up 1.5%; materials stocks down 2.1%. RBC Bearings beats Q1 estimates.
05-16 00:17
4 Analysts Have This To Say About Tango Therapeutics
Analysts' ratings for Tango Therapeutics (NASDAQ:TNGX) over the last quarter va...
03-06 21:00
Earnings Scheduled For March 5, 2026
Companies Reporting Before The Bell • Palladyne AI (NASDAQ:PDYN) is projected t...
03-05 19:11
A Peek at Tango Therapeutics's Future Earnings
Tango Therapeutics (NASDAQ:TNGX) will release its quarterly earnings report on ...
2025-11-04 03:02
Tango Therapeutics to Participate in the 46th Annual Goldman Sachs Global Healthcare Conference
Tango Therapeutics CEO Barbara Weber will participate in a fireside chat at the 46th Annual Goldman Sachs Global Healthcare Conference on June 10. The event will be livestreamed and available for replay on the company's website. Tango focuses on precision medicine for cancer using synthetic lethality principles.
2025-05-27 11:00
